GastroenterologyNews.net

Gastroenterology Xagena

Xagena Mappa
Medical Meeting
Mediexplorer.it
Ematobase.it

Search results for "Anti-TNF"

IBD ( inflammatory bowel diseases ) is a term referring to several chronic diseases that cause inflammation of the intestines, including ulcerative colitis and Crohn's disease. Symptoms for both con ...


A single 400 mg injection of Cimzia ( Certolizumab pegol, CDP 870 ) every four weeks was effective in maintaining control of the signs and symptoms of Crohn's disease following induction therapy, acco ...


A Phase III trial ( PRECiSE 1 ) data have demonstrated that when compared with placebo, a significantly greater proportion of moderate to severe Crohn's disease patients achieved clinical response wit ...


Information on efficacy and predictors of response to Adalimumab ( Humira ) in ulcerative colitis clinical practice is limited. The aim of study was assessed the response to Adalimumab and its pred ...


TNF inhibitors are effective in the treatment of ulcerative colitis. Adalimumab ( Humira ), a fully human TNF inhibitor, is increasingly used both as primary anti-TNF agent and in patients switching f ...


Data about the effectiveness of biologics, including anti-tumor necrosis factor ( anti-TNF ) therapy and anti-integrin strategies, in antibiotic refractory pouchitis or Crohn's disease-associated pouc ...


Endoscopic healing and clinical remission are important parameters to evaluate therapeutic efficacy in Crohn's disease. The aim of a study was to investigate the clinical effectiveness of Adalimumab ...


Inflammatory bowel disease [ IBD ] is associated with a 1.5- to 3-fold increased risk of venous thromboembolism [ VTE ] events. Researchers have determined the risk of venous thromboembolism in in ...


Active inflammatory bowel disease ( IBD ) adversely affects pregnancy outcomes. Little is known about the risk of relapse after stopping anti–tumor necrosis factor ( anti-TNF ) treatment during pregna ...